Nobel Laureate Dr. Honjo to Speak at BIO Asia

2020-06-10| PartnerAsia-Pacific

Nobel Laureate Dr. Honjo to Speak at BIO Asia–Taiwan 2020

by GeneOnline

Share To

Dr. Tasuku Honjo (本庶佑), Distinguished Professor of Kyoto University, Japan, shared the 2018 Nobel Prize in Medicine or Physiology for his contributions to the immune checkpoint blockade approach in cancer immunotherapy. His discoveries have been responsible in saving thousands of lives.

We are honored to announce that Dr. Tasuku Honjo will join us at BIO Asia–Taiwan 2020 as a Plenary Speaker, with his presentation titled “Future of
Cancer Immunotherapy“.

The Early Bird special ends this week! Don’t miss your chance to join thousands of bioindustry professionals from Asia and around the world at BIO Asia–Taiwan 2020 Online + Live!

BIO Asia-Taiwan 2020 Secretariat

[email protected] | www.bioasiataiwan.com | +886-2-7700-3883

Author

GeneOnline

BIO Asia-Taiwan 2024

Investment Summit Highlights: Advancements in Therapeutics & Pharmaceuticals

2024-08-02

BIO Asia-Taiwan 2024

BIO Asia-Taiwan Kicks Off with the Latest Cell and Gene Therapy Developments

2024-07-24

Special

BIO Asia-Taiwan 2022: Looking for the Exit; Startup Considerations and Strategies

2022-07-28

LATEST

Bio Asia Pacific 2024 Close ASEAN Collaborations: Catalyzing Innovation and Global Partnerships

2024-09-12

Illumina’s IVD Biomarker Test Becomes the First FDA-approved Pan-cancer Companion Diagnostics Kit

2024-09-11

Lotus Pharma Expands in Southeast Asia with Alpha Choay Acquisition from Sanofi

2024-09-06

Indian CDMO Stocks in the Spotlight: US House to Vote on BIOSECURE Act Next Week

2024-09-06

Eli Lilly Joins Forces with AI Startup Genetic Leap in $409M Deal Centered Around RNA-Targeted Drug Discovery

2024-09-06

Illumina Wins EU Court Battle, Dodges Fine, but Grail Deal Already Void

2024-09-05

Breaking New Ground for Clinical Trials with AI/ML Applications

2024-09-05

EVENT

2024-09-13

ESMO Congress 2024

Barcelona, Spain

2024-10-09

Medical Japan 2024 Tokyo

Tokyo, Japan

2024-10-10

BioJapan / Regenerative Medicine Japan / healthTECH JAPAN 2024

Tokyo, Japan

2024-10-15

BIO Investor Forum 2024

San Francisco, U.S.A.

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

GENE ONLINE|News &
Opinion
Blog